Curcumin memory study pulled before it even started
NCT ID NCT07251985
First seen Dec 24, 2025 · Last updated Jun 19, 2026 · Updated 15 times
Summary
This study was designed to see if a daily curcumin supplement could improve memory and attention in adults aged 50–85 with age-related memory complaints. Participants would have taken curcumin or a placebo for up to 12 months. However, the trial was withdrawn before enrolling anyone, so no data were collected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEMORY are added.
Genom att skicka in godkänner du våra Användarvillkor
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
curcumin (Theracurmin Super TS-P1)
What this could lead to
If it had succeeded, this could have pointed toward a natural supplement to help slow age-related memory decline.
What could go wrong
The study was withdrawn before enrolling anyone, so no results are available. Even if completed, the previous small study had modest effects, and dietary supplements often fail to show clear benefits in larger trials.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.